References

Aben, Nanne, Daniel J Vis, Magali Michaut, and Lodewyk Fa Wessels. 2016. “TANDEM: A Two-Stage Approach to Maximize Interpretability of Drug Response Models Based on Multiple Molecular Data Types.” Bioinformatics 32 (17). Oxford University Press: i413–i420.

Abeshouse, Adam, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar Amin, Christopher D Andry, Matti Annala, et al. 2015. “The Molecular Taxonomy of Primary Prostate Cancer.” Cell 163 (4). Elsevier: 1011–25.

Abou-Jaoudé, Wassim, Pedro T Monteiro, Aurélien Naldi, Maximilien Grandclaudon, Vassili Soumelis, Claudine Chaouiya, and Denis Thieffry. 2015. “Model Checking to Assess T-Helper Cell Plasticity.” Frontiers in Bioengineering and Biotechnology 2. Frontiers: 86.

Abou-Jaoudé, Wassim, Pauline Traynard, Pedro T Monteiro, Julio Saez-Rodriguez, Tomáš Helikar, Denis Thieffry, and Claudine Chaouiya. 2016. “Logical Modeling and Dynamical Analysis of Cellular Networks.” Frontiers in Genetics 7. Frontiers: 94.

Abou-Jawde, Rony, Toni Choueiri, Carlos Alemany, and Tarek Mekhail. 2003. “An Overview of Targeted Treatments in Cancer.” Clinical Therapeutics 25 (8). Elsevier: 2121–37.

Adzhubei, Ivan A., Steffen Schmidt, Leonid Peshkin, Vasily E. Ramensky, Anna Gerasimova, Peer Bork, Alexey S. Kondrashov, and Shamil R. Sunyaev. 2010. “A Method and Server for Predicting Damaging Missense Mutations.” Nature Methods 7 (4): 248–49. doi:10.1038/nmeth0410-248.

Albert, István, Juilee Thakar, Song Li, Ranran Zhang, and Réka Albert. 2008. “Boolean Network Simulations for Life Scientists.” Source Code for Biology and Medicine 3 (1). BioMed Central: 16.

Alberts, Bruce, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter. 2007. “Molecular Biology of the Cell. Garland Science.” New York 1392.

Aldridge, Bree B, Julio Saez-Rodriguez, Jeremy L Muhlich, Peter K Sorger, and Douglas A Lauffenburger. 2009. “Fuzzy Logic Analysis of Kinase Pathway Crosstalk in Tnf/Egf/Insulin-Induced Signaling.” PLoS Comput Biol 5 (4). Public Library of Science: e1000340.

Altman, Douglas G, Berthold Lausen, Willi Sauerbrei, and Martin Schumacher. 1994. “Dangers of Using ‘Optimal’ Cutpoints in the Evaluation of Prognostic Factors.” JNCI: Journal of the National Cancer Institute 86 (11). Oxford University Press: 829–35.

Altrock, Philipp M, Lin L Liu, and Franziska Michor. 2015. “The Mathematics of Cancer: Integrating Quantitative Models.” Nature Reviews Cancer 15 (12). Nature Publishing Group: 730–45.

Anderson, Alexander RA, and Vito Quaranta. 2008. “Integrative Mathematical Oncology.” Nature Reviews Cancer 8 (3). Nature Publishing Group: 227–34.

Anderson, Alexander RA, Alissa M Weaver, Peter T Cummings, and Vito Quaranta. 2006. “Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment.” Cell 127 (5). Elsevier: 905–15.

Angermueller, Christof, Tanel Pärnamaa, Leopold Parts, and Oliver Stegle. 2016. “Deep Learning for Computational Biology.” Molecular Systems Biology 12 (7): 878.

Araujo, Robyn P, and DL Sean McElwain. 2004. “A History of the Study of Solid Tumour Growth: The Contribution of Mathematical Modelling.” Bulletin of Mathematical Biology 66 (5). Elsevier: 1039–91.

Armitage, Peter, and Richard Doll. 1954. “The Age Distribution of Cancer and a Multi-Stage Theory of Carcinogenesis.” British Journal of Cancer 8 (1). Nature Publishing Group: 1.

Azuaje, Francisco. 2017. “Computational Models for Predicting Drug Responses in Cancer Research.” Briefings in Bioinformatics 18 (5). Oxford University Press: 820–29.

———. 2019. “Artificial Intelligence for Precision Oncology: Beyond Patient Stratification.” NPJ Precision Oncology 3 (1). Nature Publishing Group: 1–5.

Baar, Martina, Loren Coquille, Hannah Mayer, Michael Hölzel, Meri Rogava, Thomas Tüting, and Anton Bovier. 2016. “A Stochastic Model for Immunotherapy of Cancer.” Scientific Reports 6. Nature Publishing Group: 24169.

Bailer-Jones, Daniela M. 2002. “Scientists’ Thoughts on Scientific Models.” Perspectives on Science 10 (3). MIT Press: 275–301.

Baker, Ruth E, Jose-Maria Pena, Jayaratnam Jayamohan, and Antoine Jérusalem. 2018. “Mechanistic Models Versus Machine Learning, a Fight Worth Fighting for the Biological Community?” Biology Letters 14 (5). The Royal Society: 20170660.

Barabasi, Albert-Laszlo, and Zoltan N Oltvai. 2004. “Network Biology: Understanding the Cell’s Functional Organization.” Nature Reviews Genetics 5 (2). Nature Publishing Group: 101–13.

Barbolosi, Dominique, Joseph Ciccolini, Bruno Lacarelle, Fabrice Barlési, and Nicolas André. 2016. “Computational Oncology—mathematical Modelling of Drug Regimens for Precision Medicine.” Nature Reviews Clinical Oncology 13 (4). Nature Publishing Group: 242.

Barillot, Emmanuel, Laurence Calzone, Philippe Hupe, Jean-Philippe Vert, and Andrei Zinovyev. 2012. Computational Systems Biology of Cancer. CRC Press.

Baur, Florentin, Sarah L Nietzer, Meik Kunz, Fabian Saal, Julian Jeromin, Stephanie Matschos, Michael Linnebacher, Heike Walles, Thomas Dandekar, and Gudrun Dandekar. 2020. “Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human in Vitro Tissue Models with Boolean in Silico Models.” Cancers 12 (1). Multidisciplinary Digital Publishing Institute: 28.

Behan, Fiona M, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M Beaver, Giorgia Migliardi, Rita Santos, et al. 2019. “Prioritization of Cancer Therapeutic Targets Using Crispr–Cas9 Screens.” Nature 568 (7753). Nature Publishing Group: 511.

Bellomo, Nicola, NK Li, and Ph K Maini. 2008. “On the Foundations of Cancer Modelling: Selected Topics, Speculations, and Perspectives.” Mathematical Models and Methods in Applied Sciences 18 (04). World Scientific: 593–646.

Benzekry, Sébastien. 2020. “Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology.” Clinical Pharmacology & Therapeutics. Wiley Online Library.

Benzekry, Sébastien, Clare Lamont, Afshin Beheshti, Amanda Tracz, John ML Ebos, Lynn Hlatky, and Philip Hahnfeldt. 2014. “Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth.” PLoS Comput Biol 10 (8). Public Library of Science: e1003800.

Béal, Jonas, and Aurélien Latouche. 2020. “Causal Inference with Multiple Versions of Treatment and Application to Personalized Medicine.” ArXiv Preprint ArXiv:2005.12427.

Béal, Jonas, Arnau Montagud, Pauline Traynard, Emmanuel Barillot, and Laurence Calzone. 2019. “Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients.” Frontiers in Physiology. Frontiers Media S.A. doi:10.3389/fphys.2018.01965.

Béal, Jonas, Lorenzo Pantolini, Vincent Noël, Emmanuel Barillot, and Laurence Calzone. 2020. “Personalized Logical Models to Investigate Cancer Response to Braf Treatments in Melanomas and Colorectal Cancers.” BioRxiv. Cold Spring Harbor Laboratory.

Béal, Jonas, Elizabeth Rémy, and Laurence Calzone. 2020. “Modélisation Logique et Données Omiques : De La Construction Des Modèles à La Médecine Personnalisée.” In Approche Symbolique de La Modélisation et de L’analyse Des Systèmes Biologiques, edited by Elisabeth Rémy and Cédric Lhoussaine. ISTE.

Bhalla, Upinder S, and Ravi Iyengar. 1999. “Emergent Properties of Networks of Biological Signaling Pathways.” Science 283 (5400). American Association for the Advancement of Science: 381–87.

Bianucci, Raffaella, Antonio Perciaccante, Philippe Charlier, Otto Appenzeller, and Donatella Lippi. 2018. “Earliest Evidence of Malignant Breast Cancer in Renaissance Paintings.” The Lancet Oncology 19 (2). Elsevier: 166–67.

Bilal, Erhan, Janusz Dutkowski, Justin Guinney, In Sock Jang, Benjamin A Logsdon, Gaurav Pandey, Benjamin A Sauerwine, et al. 2013. “Improving Breast Cancer Survival Analysis Through Competition-Based Multidimensional Modeling.” PLoS Computational Biology 9 (5). Public Library of Science.

Blanche, Paul, Michael W Kattan, and Thomas A Gerds. 2019. “The c-Index Is Not Proper for the Evaluation of-Year Predicted Risks.” Biostatistics 20 (2). Oxford University Press: 347–57.

Bouhaddou, Mehdi, Anne Marie Barrette, Alan D Stern, Rick J Koch, Matthew S DiStefano, Eric A Riesel, Luis C Santos, Annie L Tan, Alex E Mertz, and Marc R Birtwistle. 2018. “A Mechanistic Pan-Cancer Pathway Model Informed by Multi-Omics Data Interprets Stochastic Cell Fate Responses to Drugs and Mitogens.” PLoS Computational Biology 14 (3). Public Library of Science: e1005985.

Bozic, Ivana, Tibor Antal, Hisashi Ohtsuki, Hannah Carter, Dewey Kim, Sining Chen, Rachel Karchin, Kenneth W Kinzler, Bert Vogelstein, and Martin A Nowak. 2010. “Accumulation of Driver and Passenger Mutations During Tumor Progression.” Proceedings of the National Academy of Sciences 107 (43). National Acad Sciences: 18545–50.

Braithwaite, Peter Allen, and Dace Shugg. 1983. “Rembrandt’s Bathsheba: The Dark Shadow of the Left Breast.” Annals of the Royal College of Surgeons of England 65 (5). Royal College of Surgeons of England: 337.

Bray, Freddie, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, and Ahmedin Jemal. 2018. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 68 (6). Wiley Online Library: 394–424.

Breiman, Leo. 2001a. “Random Forests.” Machine Learning 45 (1). Springer: 5–32.

———. 2001b. “Statistical Modeling: The Two Cultures (with Comments and a Rejoinder by the Author).” Statistical Science 16 (3). Institute of Mathematical Statistics: 199–231.

Buyse, Marc, Sherene Loi, Laura Van’t Veer, Giuseppe Viale, Mauro Delorenzi, Annuska M Glas, Mahasti Saghatchian d’Assignies, et al. 2006. “Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women with Node-Negative Breast Cancer.” Journal of the National Cancer Institute 98 (17). Oxford University Press: 1183–92.

Byrne, Helen M. 2010. “Dissecting Cancer Through Mathematics: From the Cell to the Animal Model.” Nature Reviews Cancer 10 (3). Nature Publishing Group: 221–30.

Calzone, Laurence, Emmanuel Barillot, and Andrei Zinovyev. 2018. “Logical Versus Kinetic Modeling of Biological Networks: Applications in Cancer Research.” Current Opinion in Chemical Engineering 21. Elsevier: 22–31.

Calzone, Laurence, Laurent Tournier, Simon Fourquet, Denis Thieffry, Boris Zhivotovsky, Emmanuel Barillot, and Andrei Zinovyev. 2010. “Mathematical Modelling of Cell-Fate Decision in Response to Death Receptor Engagement.” PLoS Computational Biology 6 (3). Public Library of Science.

Cantwell-Dorris, Emma R, John J O’Leary, and Orla M Sheils. 2011. “BRAFV600E: Implications for Carcinogenesis and Molecular Therapy.” Molecular Cancer Therapeutics 10 (3). AACR: 385–94.

Chakravarty, Debyani, Jianjiong Gao, Sarah Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E. Rudolph, et al. 2017. “OncoKB: A Precision Oncology Knowledge Base.” JCO Precision Oncology, no. 1 (May): 1–16. doi:10.1200/PO.17.00011.

Chapman, Paul B, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, et al. 2011. “Improved Survival with Vemurafenib in Melanoma with Braf V600e Mutation.” New England Journal of Medicine 364 (26). Mass Medical Soc: 2507–16.

Ching, Travers, Xun Zhu, and Lana X Garmire. 2018. “Cox-Nnet: An Artificial Neural Network Method for Prognosis Prediction of High-Throughput Omics Data.” PLoS Computational Biology 14 (4). Public Library of Science: e1006076.

Cho, Sung-Hwan, Sang-Min Park, Ho-Sung Lee, Hwang-Yeol Lee, and Kwang-Hyun Cho. 2016. “Attractor Landscape Analysis of Colorectal Tumorigenesis and Its Reversion.” BMC Systems Biology 10 (1). Springer: 96.

Choodari-Oskooei, Babak, Patrick Royston, and Mahesh KB Parmar. 2012. “A Simulation Study of Predictive Ability Measures in a Survival Model I: Explained Variation Measures.” Statistics in Medicine 31 (23). Wiley Online Library: 2627–43.

Christodoulou, Evangelia, Jie Ma, Gary S Collins, Ewout W Steyerberg, Jan Y Verbakel, and Ben Van Calster. 2019. “A Systematic Review Shows No Performance Benefit of Machine Learning over Logistic Regression for Clinical Prediction Models.” Journal of Clinical Epidemiology 110. Elsevier: 12–22.

Cohen, David P. A., Loredana Martignetti, Sylvie Robine, Emmanuel Barillot, Andrei Zinovyev, and Laurence Calzone. 2015. “Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.” PLOS Computational Biology 11 (11): e1004571. doi:10.1371/journal.pcbi.1004571.

Cohrs, Randall J, Tyler Martin, Parviz Ghahramani, Luc Bidaut, Paul J Higgins, and Aamir Shahzad. 2015. “Translational Medicine Definition by the European Society for Translational Medicine.” Elsevier.

Cole, Stephen R, and Miguel A Hernán. 2008. “Constructing Inverse Probability Weights for Marginal Structural Models.” American Journal of Epidemiology 168 (6). Oxford University Press: 656–64.

Collins. 2020. The Collins English Dictionary. HarperCollins.

Collombet, Samuel, Chris van Oevelen, Jose Luis Sardina Ortega, Wassim Abou-Jaoude, Bruno Di Stefano, Morgane Thomas-Chollier, Thomas Graf, and Denis Thieffry. 2017. “Logical Modeling of Lymphoid and Myeloid Cell Specification and Transdifferentiation.” Proceedings of the National Academy of Sciences 114 (23): 5792–9. doi:10.1073/pnas.1610622114.

Consortium, UniProt. 2019. “UniProt: A Worldwide Hub of Protein Knowledge.” Nucleic Acids Research 47 (D1). Oxford University Press: D506–D515.

Conway, Jake R, Alexander Lex, and Nils Gehlenborg. 2017. “UpSetR: An R Package for the Visualization of Intersecting Sets and Their Properties.” Bioinformatics 33 (18). Oxford University Press: 2938–40.

Corcoran, Ryan B, Hiromichi Ebi, Alexa B Turke, Erin M Coffee, Michiya Nishino, Alexandria P Cogdill, Ronald D Brown, et al. 2012. “EGFR-Mediated Reactivation of Mapk Signaling Contributes to Insensitivity of Braf-Mutant Colorectal Cancers to Raf Inhibition with Vemurafenib.” Cancer Discovery 2 (3). AACR: 227–35.

Cortes, Corinna, and Vladimir Vapnik. 1995. “Support-Vector Networks.” Machine Learning 20 (3). Springer: 273–97.

Costello, James C, Laura M Heiser, Elisabeth Georgii, Mehmet Gönen, Michael P Menden, Nicholas J Wang, Mukesh Bansal, et al. 2014. “A Community Effort to Assess and Improve Drug Sensitivity Prediction Algorithms.” Nature Biotechnology 32 (12). Nature Publishing Group: 1202.

Cox, David R. 1972. “Regression Models and Life-Tables.” Journal of the Royal Statistical Society: Series B (Methodological) 34 (2). Wiley Online Library: 187–202.

Coyne, Geraldine O’Sullivan, Naoko Takebe, and Alice P Chen. 2017. “Defining Precision: The Precision Medicine Initiative Trials Nci-Mpact and Nci-Match.” Current Problems in Cancer 41 (3). Elsevier: 182–93.

Cree, Ian A, Christian M Kurbacher, Alan Lamont, Andrew C Hindley, Sharon Love, TCA Ovarian Cancer Trial Group, and others. 2007. “A Prospective Randomized Controlled Trial of Tumour Chemosensitivity Assay Directed Chemotherapy Versus Physician’s Choice in Patients with Recurrent Platinum-Resistant Ovarian Cancer.” Anti-Cancer Drugs 18 (9). LWW: 1093–1101.

Crick, Francis. 1970. “Central Dogma of Molecular Biology.” Nature 227 (5258). Nature Publishing Group: 561–63.

Curtis, Christina, Sohrab P. Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M. Rueda, Mark J. Dunning, Doug Speed, et al. 2012. “The Genomic and Transcriptomic Architecture of 2,000 Breast Tumours Reveals Novel Subgroups.” Nature 486 (7403): 346–52. doi:10.1038/nature10983.

Davies, Helen, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, et al. 2002. “Mutations of the Braf Gene in Human Cancer.” Nature 417 (6892). Nature Publishing Group: 949–54.

De Gramont, Armand, Sarah Watson, Lee M Ellis, Jordi Rodón, Josep Tabernero, Aimery De Gramont, and Stanley R Hamilton. 2015. “Pragmatic Issues in Biomarker Evaluation for Targeted Therapies in Cancer.” Nature Reviews Clinical Oncology 12 (4). Nature Publishing Group: 197.

De Jong, Hidde. 2002. “Modeling and Simulation of Genetic Regulatory Systems: A Literature Review.” Journal of Computational Biology 9 (1). Mary Ann Liebert, Inc.: 67–103.

Deisboeck, Thomas S, Le Zhang, Jeongah Yoon, and Jose Costa. 2009. “In Silico Cancer Modeling: Is It Ready for Prime Time?” Nature Clinical Practice Oncology 6 (1). Nature Publishing Group: 34–42.

Del Sol, Antonio, Rudi Balling, Lee Hood, and David Galas. 2010. “Diseases as Network Perturbations.” Current Opinion in Biotechnology 21 (4). Elsevier: 566–71.

Dempster, Joshua M, Clare Pacini, Sasha Pantel, Fiona M Behan, Thomas Green, John Krill-Burger, Charlotte M Beaver, et al. 2019. “Agreement Between Two Large Pan-Cancer Crispr-Cas9 Gene Dependency Data Sets.” Nature Communications 10 (1). Nature Publishing Group: 1–14.

Ding, Li, Matthew H Bailey, Eduard Porta-Pardo, Vesteinn Thorsson, Antonio Colaprico, Denis Bertrand, David L Gibbs, et al. 2018. “Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.” Cell 173 (2). Elsevier: 305–20.

Domany, Eytan. 2014. “Using High-Throughput Transcriptomic Data for Prognosis: A Critical Overview and Perspectives.” Cancer Research 74 (17). AACR: 4612–21.

Drier, Yotam, Michal Sheffer, and Eytan Domany. 2013. “Pathway-Based Personalized Analysis of Cancer.” Proceedings of the National Academy of Sciences 110 (16). National Acad Sciences: 6388–93.

Dulbecco, Renato. 1986. “A Turning Point in Cancer Research: Sequencing the Human Genome.” Science 231. American Association for the Advancement of Science: 1055–7.

Durrett, Richard. 2015. “Branching Process Models of Cancer.” In Branching Process Models of Cancer, 1–63. Springer.

Eberhardt, Frederick, and Richard Scheines. 2007. “Interventions and Causal Inference.” Philosophy of Science 74 (5). The University of Chicago Press: 981–95.

Eduati, Federica, Victoria Doldàn-Martelli, Bertram Klinger, Thomas Cokelaer, Anja Sieber, Fiona Kogera, Mathurin Dorel, Mathew J Garnett, Nils Blüthgen, and Julio Saez-Rodriguez. 2017. “Drug Resistance Mechanisms in Colorectal Cancer Dissected with Cell Type–specific Dynamic Logic Models.” Cancer Research 77 (12). AACR: 3364–75.

Eduati, Federica, Patricia Jaaks, Jessica Wappler, Thorsten Cramer, Christoph A Merten, Mathew J Garnett, and Julio Saez-Rodriguez. 2020. “Patient-Specific Logic Models of Signaling Pathways from Screenings on Cancer Biopsies to Prioritize Personalized Combination Therapies.” Molecular Systems Biology 16 (2). John Wiley & Sons, Ltd.

Edwin, Francis, Kimberly Anderson, Chunyi Ying, and Tarun B Patel. 2009. “Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease.” Molecular Pharmacology 76 (4). ASPET: 679–91.

Elati, Mohamed, Pierre Neuvial, Monique Bolotin-Fukuhara, Emmanuel Barillot, François Radvanyi, and Céline Rouveirol. 2007. “LICORN: Learning Cooperative Regulation Networks from Gene Expression Data.” Bioinformatics 23 (18): 2407–14. doi:10.1093/bioinformatics/btm352.

Eraslan, Gökcen, Žiga Avsec, Julien Gagneur, and Fabian J Theis. 2019. “Deep Learning: New Computational Modelling Techniques for Genomics.” Nature Reviews Genetics 20 (7). Nature Publishing Group: 389–403.

Fauré, Adrien, Aurélien Naldi, Claudine Chaouiya, and Denis Thieffry. 2006. “Dynamical Analysis of a Generic Boolean Model for the Control of the Mammalian Cell Cycle.” Bioinformatics 22 (14). Oxford University Press: e124–e131.

Feng, Ping, Xiao-Hua Zhou, Qing-Ming Zou, Ming-Yu Fan, and Xiao-Song Li. 2012. “Generalized Propensity Score for Estimating the Average Treatment Effect of Multiple Treatments.” Statistics in Medicine 31 (7). Wiley Online Library: 681–97.

Ferranti, Dana, David Krane, and David Craft. 2017. “The Value of Prior Knowledge in Machine Learning of Complex Network Systems.” Bioinformatics 33 (22). Oxford University Press: 3610–8.

Fey, Dirk, Melinda Halasz, Daniel Dreidax, Sean P Kennedy, Jordan F Hastings, Nora Rauch, Amaya Garcia Munoz, et al. 2015. “Signaling Pathway Models as Biomarkers: Patient-Specific Simulations of Jnk Activity Predict the Survival of Neuroblastoma Patients.” Sci. Signal. 8 (408). American Association for the Advancement of Science: ra130–ra130.

Flaherty, Keith T, Robert Gray, Alice Chen, Shuli Li, David Patton, Stanley R Hamilton, Paul M Williams, et al. 2020. “THE Molecular Analysis for Therapy Choice (Nci-Match) Trial: LESSONS for Genomic Trial Design.” JNCI: Journal of the National Cancer Institute.

Flake, Gary William. 1998. The Computational Beauty of Nature: Computer Explorations of Fractals, Chaos, Complex Systems, and Adaptation. MIT press.

Flobak, Åsmund, Anaïs Baudot, Elisabeth Remy, Liv Thommesen, Denis Thieffry, Martin Kuiper, and Astrid Lægreid. 2015. “Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling.” PLoS Computational Biology 11 (8). Public Library of Science.

Fowler, Andrew Cadle, Anna C Fowler, and AC Fowler. 1997. Mathematical Models in the Applied Sciences. Vol. 17. Cambridge University Press.

Freidlin, Boris, Lisa M McShane, and Edward L Korn. 2010. “Randomized Clinical Trials with Biomarkers: Design Issues.” Journal of the National Cancer Institute 102 (3). Oxford University Press: 152–60.

Friedman, Adam A, Anthony Letai, David E Fisher, and Keith T Flaherty. 2015. “Precision Medicine for Cancer with Next-Generation Functional Diagnostics.” Nature Reviews Cancer 15 (12). Nature Publishing Group: 747–56.

Frigg, Roman, and Stephan Hartmann. 2020. “Models in Science.” In The Stanford Encyclopedia of Philosophy, edited by Edward N. Zalta, Spring 2020. https://plato.stanford.edu/archives/spr2020/entries/models-science/; Metaphysics Research Lab, Stanford University.

Fröhlich, Fabian, Thomas Kessler, Daniel Weindl, Alexey Shadrin, Leonard Schmiester, Hendrik Hache, Artur Muradyan, et al. 2018. “Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model.” Cell Systems 7 (6). Elsevier: 567–79.

Fumia, Herman F, and Marcelo L Martins. 2013. “Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes.” PloS One 8 (7). Public Library of Science.

Gail, Mitchell H, and Ruth M Pfeiffer. 2018. “Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.” JNCI: Journal of the National Cancer Institute 110 (9). Oxford University Press: 994–1002.

Gao, Hui, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, et al. 2015. “High-Throughput Screening Using Patient-Derived Tumor Xenografts to Predict Clinical Trial Drug Response.” Nature Medicine 21 (11). Nature Publishing Group: 1318.

Garnett, Mathew J, Elena J Edelman, Sonja J Heidorn, Chris D Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, et al. 2012. “Systematic Identification of Genomic Markers of Drug Sensitivity in Cancer Cells.” Nature 483 (7391). Nature Publishing Group: 570–75.

Ghaffarizadeh, Ahmadreza, Randy Heiland, Samuel H Friedman, Shannon M Mumenthaler, and Paul Macklin. 2018. “PhysiCell: An Open Source Physics-Based Cell Simulator for 3-d Multicellular Systems.” PLoS Computational Biology 14 (2). Public Library of Science: e1005991.

Gillespie, Daniel T. 1976. “A General Method for Numerically Simulating the Stochastic Time Evolution of Coupled Chemical Reactions.” Journal of Computational Physics 22 (4): 403–34. doi:10.1016/0021-9991(76)90041-3.

Gopal, YN Vashisht, Wanleng Deng, Scott E Woodman, Kakajan Komurov, Prahlad Ram, Paul D Smith, and Michael A Davies. 2010. “Basal and Treatment-Induced Activation of Akt Mediates Resistance to Cell Death by Azd6244 (Arry-142886) in Braf-Mutant Human Cutaneous Melanoma Cells.” Cancer Research 70 (21). AACR: 8736–47.

Grieco, Luca, Laurence Calzone, Isabelle Bernard-Pierrot, François Radvanyi, Brigitte Kahn-Perles, and Denis Thieffry. 2013. “Integrative Modelling of the Influence of Mapk Network on Cancer Cell Fate Decision.” PLoS Computational Biology 9 (10). Public Library of Science: e1003286.

Grömping, Ulrike, and others. 2006. “Relative Importance for Linear Regression in R: The Package Relaimpo.” Journal of Statistical Software 17 (1): 1–27.

Gupta, Piyush B, Christine M Fillmore, Guozhi Jiang, Sagi D Shapira, Kai Tao, Charlotte Kuperwasser, and Eric S Lander. 2011. “Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells.” Cell 146 (4). Elsevier: 633–44.

Haeno, Hiroshi, Mithat Gonen, Meghan B Davis, Joseph M Herman, Christine A Iacobuzio-Donahue, and Franziska Michor. 2012. “Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies.” Cell 148 (1-2). Elsevier: 362–75.

Hahn, William C, Christopher M Counter, Ante S Lundberg, Roderick L Beijersbergen, Mary W Brooks, and Robert A Weinberg. 1999. “Creation of Human Tumour Cells with Defined Genetic Elements.” Nature 400 (6743). Nature Publishing Group: 464–68.

Hajdu, Steven I. 2011a. “A Note from History: Landmarks in History of Cancer, Part 1.” Cancer 117 (5). Wiley Online Library: 1097–1102.

———. 2011b. “A Note from History: Landmarks in History of Cancer, Part 2.” Cancer 117 (12). Wiley Online Library: 2811–20.

———. 2012a. “A Note from History: Landmarks in History of Cancer, Part 3.” Cancer 118 (4). Wiley Online Library: 1155–68.

———. 2012b. “A Note from History: Landmarks in History of Cancer, Part 4.” Cancer 118 (20). Wiley Online Library: 4914–28.

Hajdu, Steven I, and Farbod Darvishian. 2013. “A Note from History: Landmarks in History of Cancer, Part 5.” Cancer 119 (8). Wiley Online Library: 1450–66.

Hajdu, Steven I, and Manjunath Vadmal. 2013. “A Note from History: Landmarks in History of Cancer, Part 6.” Cancer 119 (23). Wiley Online Library: 4058–82.

Han, Shujun, Yibo Ren, Wangxiao He, Huadong Liu, Zhe Zhi, Xinliang Zhu, Tielin Yang, et al. 2018. “ERK-Mediated Phosphorylation Regulates Sox10 Sumoylation and Targets Expression in Mutant Braf Melanoma.” Nature Communications 9 (1). Nature Publishing Group: 1–14.

Hanahan, Douglas, and Robert A Weinberg. 2000. “The Hallmarks of Cancer.” Cell 100 (1). Elsevier: 57–70.

———. 2011. “Hallmarks of Cancer: The Next Generation.” Cell 144 (5). Elsevier: 646–74.

Hansen, J, and R Iyengar. 2013. “Computation as the Mechanistic Bridge Between Precision Medicine and Systems Therapeutics.” Clinical Pharmacology & Therapeutics 93 (1). Wiley Online Library: 117–28.

Hart, Traver, and Jason Moffat. 2016. “BAGEL: A Computational Framework for Identifying Essential Genes from Pooled Library Screens.” BMC Bioinformatics 17 (1). Springer: 164.

Hartigan, J. A., and P. M. Hartigan. 1985. “The Dip Test of Unimodality.” The Annals of Statistics 13 (1): 70–84. doi:10.1214/aos/1176346577.

Hasin, Yehudit, Marcus Seldin, and Aldons Lusis. 2017. “Multi-Omics Approaches to Disease.” Genome Biology 18 (1). BioMed Central: 83.

Hastie, Trevor, Robert Tibshirani, and Jerome Friedman. 2009. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer Science & Business Media.

Heagerty, Patrick J, and Yingye Zheng. 2005. “Survival Model Predictive Accuracy and Roc Curves.” Biometrics 61 (1). Wiley Online Library: 92–105.

Heagerty, Patrick J, Thomas Lumley, and Margaret S Pepe. 2000. “Time-Dependent Roc Curves for Censored Survival Data and a Diagnostic Marker.” Biometrics 56 (2). Wiley Online Library: 337–44.

Hector, Suzanne, Markus Rehm, Jasmin Schmid, Joan Kehoe, Niamh McCawley, Patrick Dicker, Frank Murray, et al. 2012. “Clinical Application of a Systems Model of Apoptosis Execution for the Prediction of Colorectal Cancer Therapy Responses and Personalisation of Therapy.” Gut 61 (5). BMJ Publishing Group: 725–33.

Heijblom, Michelle, Linda M Meijer, Ton G van Leeuwen, Wiendelt Steenbergen, and Srirang Manohar. 2014. “Monte Carlo Simulations Shed Light on Bathsheba’s Suspect Breast.” Journal of Biophotonics 7 (5). Wiley Online Library: 323–31.

Heiser, Laura M, Anguraj Sadanandam, Wen-Lin Kuo, Stephen C Benz, Theodore C Goldstein, Sam Ng, William J Gibb, et al. 2012. “Subtype and Pathway Specific Responses to Anticancer Compounds in Breast Cancer.” Proceedings of the National Academy of Sciences 109 (8). National Acad Sciences: 2724–9.

Helikar, Tomáš, John Konvalina, Jack Heidel, and Jim A Rogers. 2008. “Emergent Decision-Making in Biological Signal Transduction Networks.” Proceedings of the National Academy of Sciences 105 (6). National Acad Sciences: 1913–8.

Helikar, Tomáš, Bryan Kowal, Sean McClenathan, Mitchell Bruckner, Thaine Rowley, Alex Madrahimov, Ben Wicks, Manish Shrestha, Kahani Limbu, and Jim A Rogers. 2012. “The Cell Collective: Toward an Open and Collaborative Approach to Systems Biology.” BMC Systems Biology 6 (1). BioMed Central: 96.

Henry, N Lynn, and Daniel F Hayes. 2012. “Cancer Biomarkers.” Molecular Oncology 6 (2). Wiley Online Library: 140–46.

Hernán, MA, and JM Robins. 2020. “Causal Inference: What If.” Boca Raton: Chapman & Hill/CRC.

Hernán, Miguel A, and James M Robins. 2016. “Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.” American Journal of Epidemiology 183 (8). Oxford University Press: 758–64.

Hernán, Miguel A, and Tyler J VanderWeele. 2011. “Compound Treatments and Transportability of Causal Inference.” Epidemiology (Cambridge, Mass.) 22 (3). NIH Public Access: 368.

Hewitt, C Gordon. 1917. “Conservation of Wild Life in Canada.” Nature Publishing Group.

Hidalgo, Manuel, Frederic Amant, Andrew V Biankin, Eva Budinská, Annette T Byrne, Carlos Caldas, Robert B Clarke, et al. 2014. “Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research.” Cancer Discovery 4 (9). AACR: 998–1013.

Hilden, Jørgen, and Thomas A Gerds. 2014. “A Note on the Evaluation of Novel Biomarkers: Do Not Rely on Integrated Discrimination Improvement and Net Reclassification Index.” Statistics in Medicine 33 (19). Wiley Online Library: 3405–14.

Hill, Steven M, Laura M Heiser, Thomas Cokelaer, Michael Unger, Nicole K Nesser, Daniel E Carlin, Yang Zhang, et al. 2016. “Inferring Causal Molecular Networks: Empirical Assessment Through a Community-Based Effort.” Nature Methods 13 (4). Nature Publishing Group: 310.

Hilsenbeck, Susan Galloway, Gary M Clark, and William L McGuire. 1992. “Why Do so Many Prognostic Factors Fail to Pan Out?” Breast Cancer Research and Treatment 22 (3). Springer: 197–206.

Holland, Paul W. 1986. “Statistics and Causal Inference.” Journal of the American Statistical Association 81 (396). Taylor & Francis: 945–60.

Hornberg, Jorrit J, Frank J Bruggeman, Hans V Westerhoff, and Jan Lankelma. 2006. “Cancer: A Systems Biology Disease.” Biosystems 83 (2-3). Elsevier: 81–90.

Horvitz, Daniel G, and Donovan J Thompson. 1952. “A Generalization of Sampling Without Replacement from a Finite Universe.” Journal of the American Statistical Association 47 (260). Taylor & Francis Group: 663–85.

Huang, Sui, Ingemar Ernberg, and Stuart Kauffman. 2009. “Cancer Attractors: A Systems View of Tumors from a Gene Network Dynamics and Developmental Perspective” 20 (7). Elsevier: 869–76.

Imbens, Guido W. 2000. “The Role of the Propensity Score in Estimating Dose-Response Functions.” Biometrika 87 (3). Oxford University Press: 706–10.

Iorio, Francesco, Theo A Knijnenburg, Daniel J Vis, Graham R Bignell, Michael P Menden, Michael Schubert, Nanne Aben, et al. 2016. “A Landscape of Pharmacogenomic Interactions in Cancer.” Cell 166 (3). Elsevier: 740–54.

Ishwaran, Hemant. 2007. “Variable Importance in Binary Regression Trees and Forests.” Electronic Journal of Statistics 1. The Institute of Mathematical Statistics; the Bernoulli Society: 519–37.

Jacob, François, and Jacques Monod. 1961. “Genetic Regulatory Mechanisms in the Synthesis of Proteins.” Journal of Molecular Biology 3 (3). Elsevier: 318–56.

Janes, Holly, Marshall D Brown, Ying Huang, and Margaret S Pepe. 2014. “An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection.” The International Journal of Biostatistics 10 (1). De Gruyter: 99–121.

Jastrzebski, Katarzyna, Bram Thijssen, Roelof JC Kluin, Klaas de Lint, Ian J Majewski, Roderick L Beijersbergen, and Lodewyk FA Wessels. 2018. “Integrative Modeling Identifies Key Determinants of Inhibitor Sensitivity in Breast Cancer Cell Lines.” Cancer Research 78 (15). AACR: 4396–4410.

Jemal, Ahmedin, Elizabeth M Ward, Christopher J Johnson, Kathleen A Cronin, Jiemin Ma, A Blythe Ryerson, Angela Mariotto, et al. 2017. “Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival.” JNCI: Journal of the National Cancer Institute 109 (9). Oxford University Press: djx030.

Jones, Siân, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, et al. 2008. “Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses.” Science 321 (5897). American Association for the Advancement of Science: 1801–6.

Kanehisa, Minoru, Susumu Goto, Yoko Sato, Miho Furumichi, and Mao Tanabe. 2012. “KEGG for Integration and Interpretation of Large-Scale Molecular Data Sets.” Nucleic Acids Research 40 (D1). Oxford University Press: D109–D114.

Kauffman, Stuart. 1969. “Homeostasis and Differentiation in Random Genetic Control Networks.” Nature 224 (5215). Springer: 177–78.

Khan, Faiz M, Stephan Marquardt, Shailendra K Gupta, Susanne Knoll, Ulf Schmitz, Alf Spitschak, David Engelmann, Julio Vera, Olaf Wolkenhauer, and Brigitte M Pützer. 2017. “Unraveling a Tumor Type-Specific Regulatory Core Underlying E2f1-Mediated Epithelial-Mesenchymal Transition to Predict Receptor Protein Signatures.” Nature Communications 8 (1). Nature Publishing Group: 1–15.

Kim, Yongsoo, Tycho Bismeijer, Wilbert Zwart, Lodewyk FA Wessels, and Daniel J Vis. 2019. “Genomic Data Integration by Won-Parafac Identifies Interpretable Factors for Predicting Drug-Sensitivity in Vivo.” Nature Communications 10 (1). Nature Publishing Group: 1–12.

Kirk, Paul, Thomas Thorne, and Michael PH Stumpf. 2013. “Model Selection in Systems and Synthetic Biology.” Current Opinion in Biotechnology 24 (4). Elsevier: 767–74.

Kitano, Hiroaki. 2002. “Computational Systems Biology.” Nature 420 (6912). Nature Publishing Group: 206–10.

Klarner, Hannes, Adam Streck, and Heike Siebert. 2016. “PyBoolNet: A Python Package for the Generation, Analysis and Visualization of Boolean Networks.” Bioinformatics 33 (5). Oxford University Press: 770–72.

Klinger, Bertram, Anja Sieber, Raphaela Fritsche-Guenther, Franziska Witzel, Leanne Berry, Dirk Schumacher, Yibing Yan, et al. 2013. “Network Quantification of Egfr Signaling Unveils Potential for Targeted Combination Therapy.” Molecular Systems Biology 9 (1). John Wiley & Sons, Ltd.

Knijnenburg, Theo A, Gunnar W Klau, Francesco Iorio, Mathew J Garnett, Ultan McDermott, Ilya Shmulevich, and Lodewyk FA Wessels. 2016. “Logic Models to Predict Continuous Outputs Based on Binary Inputs with an Application to Personalized Cancer Therapy.” Scientific Reports 6 (1). Nature Publishing Group: 1–14.

Knudson, Alfred G. 1971. “Mutation and Cancer: Statistical Study of Retinoblastoma.” Proceedings of the National Academy of Sciences 68 (4). National Acad Sciences: 820–23.

Knuuttila, Tarja, and Andrea Loettgers. 2017. “Modelling as Indirect Representation? The Lotka–Volterra Model Revisited.” The British Journal for the Philosophy of Science 68 (4). Oxford University Press: 1007–36.

Koltai, Mihály, Vincent Noel, Andrei Zinovyev, Laurence Calzone, and Emmanuel Barillot. 2020. “Exact Solving and Sensitivity Analysis of Stochastic Continuous Time Boolean Models.” BMC Bioinformatics 21 (1). Springer: 1–22.

Kopetz, S, J Desai, E Chan, JR Hecht, PJ O’dwyer, RJ Lee, KB Nolop, and L Saltz. 2010. “PLX4032 in Metastatic Colorectal Cancer Patients with Mutant Braf Tumors.” Journal of Clinical Oncology 28 (15_suppl). American Society of Clinical Oncology: 3534–4.

Kreeger, Pamela K, and Douglas A Lauffenburger. 2010. “Cancer Systems Biology: A Network Modeling Perspective.” Carcinogenesis 31 (1). Oxford University Press: 2–8.

Kumar, Prateek, Steven Henikoff, and Pauline C. Ng. 2009. “Predicting the Effects of Coding Non-Synonymous Variants on Protein Function Using the SIFT Algorithm.” Nature Protocols 4 (7): 1073. doi:10.1038/nprot.2009.86.

Kuperstein, I, E Bonnet, HA Nguyen, D Cohen, E Viara, L Grieco, S Fourquet, et al. 2015. “Atlas of Cancer Signalling Network: A Systems Biology Resource for Integrative Analysis of Cancer Data with Google Maps.” Oncogenesis 4 (7). Nature Publishing Group: e160–e160.

Kurilov, Roman, Benjamin Haibe-Kains, and Benedikt Brors. 2020. “Assessment of Modelling Strategies for Drug Response Prediction in Cell Lines and Xenografts.” Scientific Reports 10 (1). Nature Publishing Group: 1–11.

Lake, David, Sonia AL Corrêa, and Jürgen Müller. 2016. “Negative Feedback Regulation of the Erk1/2 Mapk Pathway.” Cellular and Molecular Life Sciences 73 (23). Springer: 4397–4413.

Lander, Eric S. 2011. “Initial Impact of the Sequencing of the Human Genome.” Nature 470 (7333). Nature Publishing Group: 187–97.

Lander, Eric S, Lauren M Linton, Bruce Birren, Chad Nusbaum, Michael C Zody, Jennifer Baldwin, Keri Devon, et al. 2001. “Initial Sequencing and Analysis of the Human Genome.” Macmillan Publishers Ltd.

Le Novere, Nicolas. 2015. “Quantitative and Logic Modelling of Molecular and Gene Networks.” Nature Reviews Genetics 16 (3). Nature Publishing Group: 146–58.

Le Tourneau, Christophe, Jean-Pierre Delord, Anthony Gonçalves, Céline Gavoille, Coraline Dubot, Nicolas Isambert, Mario Campone, et al. 2015. “Molecularly Targeted Therapy Based on Tumour Molecular Profiling Versus Conventional Therapy for Advanced Cancer (Shiva): A Multicentre, Open-Label, Proof-of-Concept, Randomised, Controlled Phase 2 Trial.” The Lancet Oncology 16 (13). Elsevier: 1324–34.

Lee, Jin-Ku, Zhaoqi Liu, Jason K Sa, Sang Shin, Jiguang Wang, Mykola Bordyuh, Hee Jin Cho, et al. 2018. “Pharmacogenomic Landscape of Patient-Derived Tumor Cells Informs Precision Oncology Therapy.” Nature Genetics 50 (10). Nature Publishing Group: 1399–1411.

Lefebvre, Celine, Presha Rajbhandari, Mariano J. Alvarez, Pradeep Bandaru, Wei Keat Lim, Mai Sato, Kai Wang, et al. 2010. “A Human B-Cell Interactome Identifies MYB and FOXM1 as Master Regulators of Proliferation in Germinal Centers.” Molecular Systems Biology 6 (June): 377. doi:10.1038/msb.2010.31.

Lehr, Stefan, Jorg Kotzka, Haluk Avci, Albert Sickmann, Helmut E Meyer, Armin Herkner, and Dirk Muller-Wieland. 2004. “Identification of Major Erk-Related Phosphorylation Sites in Gab1.” Biochemistry 43 (38). ACS Publications: 12133–40.

Letort, Gaelle, Arnau Montagud, Gautier Stoll, Randy Heiland, Emmanuel Barillot, Paul Macklin, Andrei Zinovyev, and Laurence Calzone. 2019. “PhysiBoSS: A Multi-Scale Agent-Based Modelling Framework Integrating Physical Dimension and Cell Signalling.” Bioinformatics 35 (7). Oxford University Press: 1188–96.

Li, Kun, Qunfeng Guo, Jun Yang, Hui Chen, Kewen Hu, Juan Zhao, Shunxin Zheng, et al. 2017. “FOXD3 Is a Tumor Suppressor of Colon Cancer by Inhibiting Egfr-Ras-Raf-Mek-Erk Signal Pathway.” Oncotarget 8 (3). Impact Journals, LLC: 5048.

Lindeman, Richard Harold. 1980. Introduction to Bivariate and Multivariate Analysis. Glenview, Ill: Scott, Foresman.

Liu, Jianfang, Tara Lichtenberg, Katherine A Hoadley, Laila M Poisson, Alexander J Lazar, Andrew D Cherniack, Albert J Kovatich, et al. 2018. “An Integrated Tcga Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.” Cell 173 (2). Elsevier: 400–416.

Lotka, AJ. 1925. “Principles of Physical Biology.” Baltimore: Waverly.

Luque-Fernandez, Miguel Angel, Michael Schomaker, Bernard Rachet, and Mireille E Schnitzer. 2018. “Targeted Maximum Likelihood Estimation for a Binary Treatment: A Tutorial.” Statistics in Medicine 37 (16). Wiley Online Library: 2530–46.

Ma, Jianzhu, Michael Ku Yu, Samson Fong, Keiichiro Ono, Eric Sage, Barry Demchak, Roded Sharan, and Trey Ideker. 2018. “Using Deep Learning to Model the Hierarchical Structure and Function of a Cell.” Nature Methods 15 (4). Nature Publishing Group: 290.

Manica, Matteo, Ali Oskooei, Jannis Born, Vigneshwari Subramanian, Julio Sáez-Rodríguez, and María Rodríguez Martínez. 2019. “Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders.” Molecular Pharmaceutics. ACS Publications.

Manzano, José Luís, Laura Layos, Cristina Bugés, María de los Llanos Gil, Laia Vila, Eva Martinez-Balibrea, and Anna Martínez-Cardús. 2016. “Resistant Mechanisms to Braf Inhibitors in Melanoma.” Annals of Translational Medicine 4 (12). AME Publications.

Margolin, Adam A., Ilya Nemenman, Katia Basso, Chris Wiggins, Gustavo Stolovitzky, Riccardo Dalla Favera, and Andrea Califano. 2006. “ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context.” BMC Bioinformatics 7 (1): S7. doi:10.1186/1471-2105-7-S1-S7.

Markevich, Nick I, Jan B Hoek, and Boris N Kholodenko. 2004. “Signaling Switches and Bistability Arising from Multisite Phosphorylation in Protein Kinase Cascades.” The Journal of Cell Biology 164 (3). Rockefeller University Press: 353–59.

Martignetti, Loredana, Laurence Calzone, Eric Bonnet, Emmanuel Barillot, and Andrei Zinovyev. 2016. “ROMA: Representation and Quantification of Module Activity from Target Expression Data.” Frontiers in Genetics 7. Frontiers: 18.

Mboup, Bassirou, Paul Blanche, and Aurélien Latouche. 2020. “On Evaluating How Well a Biomarker Can Predict Treatment Response with Survival Data.” Pharmaceutical Statistics. Wiley Online Library.

McShane, Lisa M, Douglas G Altman, Willi Sauerbrei, Sheila E Taube, Massimo Gion, and Gary M Clark. 2005. “Reporting Recommendations for Tumor Marker Prognostic Studies (Remark).” Journal of the National Cancer Institute 97 (16). Oxford University Press: 1180–4.

Meer, Dieudonne van der, Syd Barthorpe, Wanjuan Yang, Howard Lightfoot, Caitlin Hall, James Gilbert, Hayley E Francies, and Mathew J Garnett. 2019. “Cell Model Passports—a Hub for Clinical, Genetic and Functional Datasets of Preclinical Cancer Models.” Nucleic Acids Research 47 (D1). Oxford University Press: D923–D929.

Meinshausen, Nicolai, Alain Hauser, Joris M Mooij, Jonas Peters, Philip Versteeg, and Peter Bühlmann. 2016. “Methods for Causal Inference from Gene Perturbation Experiments and Validation.” Proceedings of the National Academy of Sciences 113 (27). National Acad Sciences: 7361–8.

Mermel, Craig H., Steven E. Schumacher, Barbara Hill, Matthew L. Meyerson, Rameen Beroukhim, and Gad Getz. 2011. “GISTIC2.0 Facilitates Sensitive and Confident Localization of the Targets of Focal Somatic Copy-Number Alteration in Human Cancers.” Genome Biology 12 (April): R41. doi:10.1186/gb-2011-12-4-r41.

Meyers, Robin M, Jordan G Bryan, James M McFarland, Barbara A Weir, Ann E Sizemore, Han Xu, Neekesh V Dharia, et al. 2017. “Computational Correction of Copy Number Effect Improves Specificity of Crispr–Cas9 Essentiality Screens in Cancer Cells.” Nature Genetics 49 (12). Nature Publishing Group: 1779–84.

Meyerson, Matthew, Stacey Gabriel, and Gad Getz. 2010. “Advances in Understanding Cancer Genomes Through Second-Generation Sequencing.” Nature Reviews Genetics 11 (10). Nature Publishing Group: 685–96.

Miller, Iain, Mingwei Min, Chen Yang, Chengzhe Tian, Sara Gookin, Dylan Carter, and Sabrina L Spencer. 2018. “Ki67 Is a Graded Rather Than a Binary Marker of Proliferation Versus Quiescence.” Cell Reports 24 (5). Elsevier: 1105–12.

Montagud, Arnau, Pauline Traynard, Loredana Martignetti, Eric Bonnet, Emmanuel Barillot, Andrei Zinovyev, and Laurence Calzone. 2017. “Conceptual and Computational Framework for Logical Modelling of Biological Networks Deregulated in Diseases.” Briefings in Bioinformatics. doi:10.1093/bib/bbx163.

Mourragui, Soufiane, Marco Loog, Mark A Van De Wiel, Marcel JT Reinders, and Lodewyk FA Wessels. 2019. “PRECISE: A Domain Adaptation Approach to Transfer Predictors of Drug Response from Pre-Clinical Models to Tumors.” Bioinformatics 35 (14). Oxford University Press: i510–i519.

Mourragui, Soufiane, Marco Loog, Daniel J Vis, Kat Moore, Anna Gonzalez Manjon, Mark A van de Wiel, Marcel JT Reinders, and Lodewyk FA Wessels. 2020. “PRECISE+ Predicts Drug Response in Patients by Non-Linear Subspace-Based Transfer from Cell Lines and Pdx Models.” BioRxiv. Cold Spring Harbor Laboratory.

Murphy, Á C, Birgit Weyhenmeyer, Jasmin Schmid, Seán M Kilbride, Markus Rehm, Heinrich J Huber, C Senft, et al. 2013. “Activation of Executioner Caspases Is a Predictor of Progression-Free Survival in Glioblastoma Patients: A Systems Medicine Approach.” Cell Death & Disease 4 (5). Nature Publishing Group: e629–e629.

Müssel, Christoph, Martin Hopfensitz, and Hans A Kestler. 2010. “BoolNet?an R Package for Generation, Reconstruction and Analysis of Boolean Networks.” Bioinformatics 26 (10). Oxford University Press: 1378–80.

Naldi, Aurélien. 2018. “BioLQM: A Java Toolkit for the Manipulation and Conversion of Logical Qualitative Models of Biological Networks.” Frontiers in Physiology 9. Frontiers: 1605.

Naldi, Aurélien, Céline Hernandez, Wassim Abou-Jaoudé, Pedro T Monteiro, Claudine Chaouiya, and Denis Thieffry. 2018. “Logical Modeling and Analysis of Cellular Regulatory Networks with Ginsim 3.0.” Frontiers in Physiology 9. Frontiers Media SA.

Naldi, Aurélien, Céline Hernandez, Nicolas Levy, Gautier Stoll, Pedro T Monteiro, Claudine Chaouiya, Tomáš Helikar, et al. 2018. “The Colomoto Interactive Notebook: Accessible and Reproducible Computational Analyses for Qualitative Biological Networks.” Frontiers in Physiology 9. Frontiers: 680.

Navin, Nicholas E. 2015. “The First Five Years of Single-Cell Cancer Genomics and Beyond.” Genome Research 25 (10). Cold Spring Harbor Lab: 1499–1507.

Network, Cancer Genome Atlas Research, and others. 2008. “Comprehensive Genomic Characterization Defines Human Glioblastoma Genes and Core Pathways.” Nature 455 (7216). Nature Publishing Group: 1061.

Nicolò, Chiara, Cynthia Périer, Melanie Prague, Carine Bellera, Gaëtan MacGrogan, Olivier Saut, and Sébastien Benzekry. 2020. “Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.” JCO Clinical Cancer Informatics 4. American Society of Clinical Oncology: 259–74.

Novère, Nicolas Le, Michael Hucka, Huaiyu Mi, Stuart Moodie, Falk Schreiber, Anatoly Sorokin, Emek Demir, et al. 2009. “The Systems Biology Graphical Notation.” Nature Biotechnology 27 (8): 735–41. doi:10.1038/nbt.1558.

Nowell, Peter C. 1976. “The Clonal Evolution of Tumor Cell Populations.” Science 194 (4260). American Association for the Advancement of Science: 23–28.

Oldenhuis, CNAM, SF Oosting, JA Gietema, and EGE De Vries. 2008. “Prognostic Versus Predictive Value of Biomarkers in Oncology.” European Journal of Cancer 44 (7). Elsevier: 946–53.

Ostrowski, M., L. Paulevé, T. Schaub, A. Siegel, and C. Guziolowski. 2016. “Boolean Network Identification from Perturbation Time Series Data Combining Dynamics Abstraction and Logic Programming.” Biosystems, Selected papers from the Computational Methods in Systems Biology 2015 conference, 149 (November): 139–53. doi:10.1016/j.biosystems.2016.07.009.

Paulevé, Loïc. 2017. “Pint: A Static Analyzer for Transient Dynamics of Qualitative Networks with IPython Interface.” In CMSB 2017 - 15th conference on Computational Methods for Systems Biology, 10545:370–16. Lecture Notes in Computer Science. Springer. doi:10.1007/978-3-319-67471-1\_20.

Pawson, T, and N Warner. 2007. “Oncogenic Re-Wiring of Cellular Signaling Pathways.” Oncogene 26 (9). Nature Publishing Group: 1268–75.

Pencina, Michael J, Ralph B D’Agostino Sr, Ralph B D’Agostino Jr, and Ramachandran S Vasan. 2008. “Evaluating the Added Predictive Ability of a New Marker: From Area Under the Roc Curve to Reclassification and Beyond.” Statistics in Medicine 27 (2). Wiley Online Library: 157–72.

Pepe, Margaret S, Ziding Feng, Ying Huang, Gary Longton, Ross Prentice, Ian M Thompson, and Yingye Zheng. 2008. “Integrating the Predictiveness of a Marker with Its Performance as a Classifier.” American Journal of Epidemiology 167 (3). Oxford University Press: 362–68.

Pepe, Margaret S, Holly Janes, and Christopher I Li. 2014. “Net Risk Reclassification P Values: Valid or Misleading?” Journal of the National Cancer Institute 106 (4). Oxford University Press US: dju041.

Pereira, Bernard, Suet-Feung Chin, Oscar M. Rueda, Hans-Kristian Moen Vollan, Elena Provenzano, Helen A. Bardwell, Michelle Pugh, et al. 2016. “The Somatic Mutation Profiles of 2,433 Breast Cancers Refines Their Genomic and Transcriptomic Landscapes.” Nature Communications 7 (May). doi:10.1038/ncomms11479.

Perfetto, Livia, Leonardo Briganti, Alberto Calderone, Andrea Cerquone Perpetuini, Marta Iannuccelli, Francesca Langone, Luana Licata, et al. 2016. “SIGNOR: A Database of Causal Relationships Between Biological Entities.” Nucleic Acids Research 44 (D1). Oxford University Press: D548–D554.

Perou, Charles M, Stefanie S Jeffrey, Matt Van De Rijn, Christian A Rees, Michael B Eisen, Douglas T Ross, Alexander Pergamenschikov, et al. 1999. “Distinctive Gene Expression Patterns in Human Mammary Epithelial Cells and Breast Cancers.” Proceedings of the National Academy of Sciences 96 (16). National Acad Sciences: 9212–7.

Perou, Charles M, Therese Sørlie, Michael B Eisen, Matt Van De Rijn, Stefanie S Jeffrey, Christian A Rees, Jonathan R Pollack, et al. 2000. “Molecular Portraits of Human Breast Tumours.” Nature 406 (6797). Nature Publishing Group: 747–52.

Polynikis, Athanasios, SJ Hogan, and Mario di Bernardo. 2009. “Comparing Different Ode Modelling Approaches for Gene Regulatory Networks.” Journal of Theoretical Biology 261 (4). Elsevier: 511–30.

Potochnik, Angela. 2017. Idealization and the Aims of Science. University of Chicago Press.

Poulikakos, Poulikos I, Yogindra Persaud, Manickam Janakiraman, Xiangju Kong, Charles Ng, Gatien Moriceau, Hubing Shi, et al. 2011. “RAF Inhibitor Resistance Is Mediated by Dimerization of Aberrantly Spliced Braf (V600e).” Nature 480 (7377). Nature Publishing Group: 387.

Powathil, Gibin G, Maciej Swat, and Mark AJ Chaplain. 2015. “Systems Oncology: Towards Patient-Specific Treatment Regimes Informed by Multiscale Mathematical Modelling.” In Seminars in Cancer Biology, 30:13–20. Elsevier.

Prahallad, Anirudh, Chong Sun, Sidong Huang, Federica Di Nicolantonio, Ramon Salazar, Davide Zecchin, Roderick L Beijersbergen, Alberto Bardelli, and René Bernards. 2012. “Unresponsiveness of Colon Cancer to Braf (V600e) Inhibition Through Feedback Activation of Egfr.” Nature 483 (7387). Nature Publishing Group: 100–103.

Razzaq, Misbah, Loïc Paulevé, Anne Siegel, Julio Saez-Rodriguez, Jérémie Bourdon, and Carito Guziolowski. 2018. “Computational Discovery of Dynamic Cell Line Specific Boolean Networks from Multiplex Time-Course Data.” PLoS Computational Biology 14 (10). Public Library of Science: e1006538.

Reddy, E Premkumar, Roberta K Reynolds, Eugenio Santos, and Mariano Barbacid. 1982. “A Point Mutation Is Responsible for the Acquisition of Transforming Properties by the T24 Human Bladder Carcinoma Oncogene.” Nature 300 (5888). Nature Publishing Group: 149–52.

Remy, Elisabeth, Sandra Rebouissou, Claudine Chaouiya, Andrei Zinovyev, François Radvanyi, and Laurence Calzone. 2015. “A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.” Cancer Research 75 (19). AACR: 4042–52.

Reuter, Jason A, Damek V Spacek, and Michael P Snyder. 2015. “High-Throughput Sequencing Technologies.” Molecular Cell 58 (4). Elsevier: 586–97.

Robins, James M, Miguel Angel Hernan, and Babette Brumback. 2000. “Marginal Structural Models and Causal Inference in Epidemiology.” LWW.

Rodon, Jordi, Jean-Charles Soria, Raanan Berger, Wilson H Miller, Eitan Rubin, Aleksandra Kugel, Apostolia Tsimberidou, et al. 2019. “Genomic and Transcriptomic Profiling Expands Precision Cancer Medicine: The Winther Trial.” Nature Medicine 25 (5). Nature Publishing Group: 751.

Rosenblueth, Arturo, and Norbert Wiener. 1945. “The Role of Models in Science.” Philosophy of Science 12 (4). Williams; Wilkins Co.: 316–21.

Rossi, Alessandro, Michela Roberto, Martina Panebianco, Andrea Botticelli, Federica Mazzuca, and Paolo Marchetti. 2019. “Drug Resistance of Braf-Mutant Melanoma: Review of up-to-Date Mechanisms of Action and Promising Targeted Agents.” European Journal of Pharmacology. Elsevier, 172621.

Royston, Patrick. 2006. “Explained Variation for Survival Models.” The Stata Journal 6 (1). SAGE Publications Sage CA: Los Angeles, CA: 83–96.

Royston, Patrick, and Willi Sauerbrei. 2004. “A New Measure of Prognostic Separation in Survival Data.” Statistics in Medicine 23 (5). Wiley Online Library: 723–48.

Rubin, Donald B. 1974. “Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies.” Journal of Educational Psychology 66 (5). American Psychological Association: 688.

———. 1980. “Randomization Analysis of Experimental Data: The Fisher Randomization Test Comment.” Journal of the American Statistical Association 75 (371). JSTOR: 591–93.

Saez-Rodriguez, Julio, Leonidas G Alexopoulos, MingSheng Zhang, Melody K Morris, Douglas A Lauffenburger, and Peter K Sorger. 2011a. “Comparing Signaling Networks Between Normal and Transformed Hepatocytes Using Discrete Logical Models.” Cancer Research 71 (16). AACR: 5400–5411.

Saez-Rodriguez, Julio, Leonidas G. Alexopoulos, MingSheng Zhang, Melody K. Morris, Douglas A. Lauffenburger, and Peter K. Sorger. 2011b. “Comparing Signaling Networks Between Normal and Transformed Hepatocytes Using Discrete Logical Models.” Cancer Research 71 (16): 5400–5411. doi:10.1158/0008-5472.CAN-10-4453.

Saez-Rodriguez, Julio, and Nils Blüthgen. 2020. “Personalized Signaling Models for Personalized Treatments.” Molecular Systems Biology 16 (1). John Wiley & Sons, Ltd.

Sahin, Özgür, Holger Fröhlich, Christian Löbke, Ulrike Korf, Sara Burmester, Meher Majety, Jens Mattern, et al. 2009. “Modeling Erbb Receptor-Regulated G1/S Transition to Find Novel Targets for de Novo Trastuzumab Resistance.” BMC Systems Biology 3 (1). BioMed Central: 1.

Salvucci, Manuela, Arman Rahman, Alexa J Resler, Girish M Udupi, Deborah A McNamara, Elaine W Kay, Pierre Laurent-Puig, et al. 2019. “A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic.” JCO Clinical Cancer Informatics 3. American Society of Clinical Oncology: 1–17.

Salvucci, Manuela, Maximilian L Würstle, Clare Morgan, Sarah Curry, Mattia Cremona, Andreas U Lindner, Orna Bacon, et al. 2017. “A Stepwise Integrated Approach to Personalized Risk Predictions in Stage Iii Colorectal Cancer.” Clinical Cancer Research 23 (5). AACR: 1200–1212.

Salvucci, Manuela, Zaitun Zakaria, Steven Carberry, Amanda Tivnan, Volker Seifert, Donat Kögel, Brona M Murphy, and Jochen HM Prehn. 2019. “System-Based Approaches as Prognostic Tools for Glioblastoma.” BMC Cancer 19 (1). Springer: 1092.

Samuels, Yardena, Zhenghe Wang, Alberto Bardelli, Natalie Silliman, Janine Ptak, Steve Szabo, Hai Yan, et al. 2004. “High Frequency of Mutations of the Pik3ca Gene in Human Cancers.” Science 304 (5670). American Association for the Advancement of Science: 554–54.

Sanchez-Vega, Francisco, Marco Mina, Joshua Armenia, Walid K Chatila, Augustin Luna, Konnor C La, Sofia Dimitriadoy, et al. 2018. “Oncogenic Signaling Pathways in the Cancer Genome Atlas.” Cell 173 (2). Elsevier: 321–37.

Sargent, Daniel J, Barbara A Conley, Carmen Allegra, and Laurence Collette. 2005. “Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials.” Journal of Clinical Oncology 23 (9). American Society of Clinical Oncology: 2020–7.

Sauerbrei, Willi, Sheila E Taube, Lisa M McShane, Margaret M Cavenagh, and Douglas G Altman. 2018. “Reporting Recommendations for Tumor Marker Prognostic Studies (Remark): An Abridged Explanation and Elaboration.” JNCI: Journal of the National Cancer Institute 110 (8). Oxford University Press: 803–11.

Sawyers, Charles L. 2008. “The Cancer Biomarker Problem.” Nature 452 (7187). Nature Publishing Group: 548–52.

Schemper, Michael. 2003. “Predictive Accuracy and Explained Variation.” Statistics in Medicine 22 (14). Wiley Online Library: 2299–2308.

Sendak, Mark P, Michael Gao, Nathan Brajer, and Suresh Balu. 2020. “Presenting Machine Learning Model Information to Clinical End Users with Model Facts Labels.” NPJ Digital Medicine 3 (1). Nature Publishing Group: 1–4.

Stadler, Zsofia K, Kasmintan A Schrader, Joseph Vijai, Mark E Robson, and Kenneth Offit. 2014. “Cancer Genomics and Inherited Risk.” Journal of Clinical Oncology 32 (7). American Society of Clinical Oncology: 687.

Steinway, Steven Nathaniel, Jorge Gomez Tejeda Zañudo, Paul J Michel, David J Feith, Thomas P Loughran, and Reka Albert. 2015. “Combinatorial Interventions Inhibit Tgf\(\beta\)-Driven Epithelial-to-Mesenchymal Transition and Support Hybrid Cellular Phenotypes.” NPJ Systems Biology and Applications 1. Nature Publishing Group: 15014.

Stoll, Gautier, Barthélémy Caron, Eric Viara, Aurélien Dugourd, Andrei Zinovyev, Aurélien Naldi, Guido Kroemer, Emmanuel Barillot, and Laurence Calzone. 2017. “MaBoSS 2.0: An Environment for Stochastic Boolean Modeling.” Bioinformatics 33 (14). Oxford University Press: 2226–8.

Stoll, Gautier, Eric Viara, Emmanuel Barillot, and Laurence Calzone. 2012. “Continuous Time Boolean Modeling for Biological Signaling: Application of Gillespie Algorithm.” BMC Systems Biology 6 (1). BioMed Central: 116.

Stratton, Michael R, Peter J Campbell, and P Andrew Futreal. 2009. “The Cancer Genome.” Nature 458 (7239). Nature Publishing Group: 719–24.

Sun, Chong, Liqin Wang, Sidong Huang, Guus JJE Heynen, Anirudh Prahallad, Caroline Robert, John Haanen, et al. 2014. “Reversible and Adaptive Resistance to Braf (V600e) Inhibition in Melanoma.” Nature 508 (7494). Nature Publishing Group: 118–22.

Swanson, Kristin R, Carly Bridge, JD Murray, and Ellsworth C Alvord Jr. 2003. “Virtual and Real Brain Tumors: Using Mathematical Modeling to Quantify Glioma Growth and Invasion.” Journal of the Neurological Sciences 216 (1). Elsevier: 1–10.

Søreide, Kjetil. 2009. “Receiver-Operating Characteristic Curve Analysis in Diagnostic, Prognostic and Predictive Biomarker Research.” Journal of Clinical Pathology 62 (1). BMJ Publishing Group: 1–5.

TCGA, and others. 2012. “Comprehensive Molecular Portraits of Human Breast Tumours.” Nature 490 (7418). Nature Publishing Group: 61.

Terfve, Camille D. A., Edmund H. Wilkes, Pedro Casado, Pedro R. Cutillas, and Julio Saez-Rodriguez. 2015. “Large-Scale Models of Signal Propagation in Human Cells Derived from Discovery Phosphoproteomic Data.” Nature Communications 6 (September): 8033. doi:10.1038/ncomms9033.

Terfve, Camille, Thomas Cokelaer, David Henriques, Aidan MacNamara, Emanuel Goncalves, Melody K. Morris, Martijn van Iersel, Douglas A. Lauffenburger, and Julio Saez-Rodriguez. 2012. “CellNOptR: A Flexible Toolkit to Train Protein Signaling Networks to Data Using Multiple Logic Formalisms.” BMC Systems Biology 6 (1): 133. doi:10.1186/1752-0509-6-133.

Teschendorff, Andrew E, Ali Naderi, Nuno L Barbosa-Morais, and Carlos Caldas. 2006. “PACK: Profile Analysis Using Clustering and Kurtosis to Find Molecular Classifiers in Cancer.” Bioinformatics 22 (18). Oxford University Press: 2269–75.

Therasse, Patrick, Susan G Arbuck, Elizabeth A Eisenhauer, Jantien Wanders, Richard S Kaplan, Larry Rubinstein, Jaap Verweij, et al. 2000. “New Guidelines to Evaluate the Response to Treatment in Solid Tumors.” Journal of the National Cancer Institute 92 (3). Oxford University Press: 205–16.

Thomas, René. 1973. “Boolean Formalization of Genetic Control Circuits.” Journal of Theoretical Biology 42 (3). Elsevier: 563–85.

Thomas, René, and Richard d’Ari. 1990. Biological Feedback. CRC press.

Tokheim, Collin J., Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, and Rachel Karchin. 2016. “Evaluating the Evaluation of Cancer Driver Genes.” Proceedings of the National Academy of Sciences 113 (50): 14330–5. doi:10.1073/pnas.1616440113.

Tomasetti, Cristian, and Bert Vogelstein. 2015. “Variation in Cancer Risk Among Tissues Can Be Explained by the Number of Stem Cell Divisions.” Science 347 (6217). American Association for the Advancement of Science: 78–81.

Tomasetti, Cristian, Luigi Marchionni, Martin A Nowak, Giovanni Parmigiani, and Bert Vogelstein. 2015. “Only Three Driver Gene Mutations Are Required for the Development of Lung and Colorectal Cancers.” Proceedings of the National Academy of Sciences 112 (1). National Acad Sciences: 118–23.

Tomlins, Scott A, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, et al. 2005. “Recurrent Fusion of Tmprss2 and Ets Transcription Factor Genes in Prostate Cancer.” Science 310 (5748). American Association for the Advancement of Science: 644–48.

Trefois, Christophe, Paul MA Antony, Jorge Goncalves, Alexander Skupin, and Rudi Balling. 2015. “Critical Transitions in Chronic Disease: Transferring Concepts from Ecology to Systems Medicine.” Current Opinion in Biotechnology 34. Elsevier: 48–55.

Tyson, John J, William T Baumann, Chun Chen, Anael Verdugo, Iman Tavassoly, Yue Wang, Louis M Weiner, and Robert Clarke. 2011. “Dynamic Modelling of Oestrogen Signalling and Cell Fate in Breast Cancer Cells.” Nature Reviews Cancer 11 (7). Nature Publishing Group: 523–32.

Tyson, John J, Katherine C Chen, and Bela Novak. 2003. “Sniffers, Buzzers, Toggles and Blinkers: Dynamics of Regulatory and Signaling Pathways in the Cell.” Current Opinion in Cell Biology 15 (2). Elsevier: 221–31.

Ursem, Carling, Chloe E Atreya, and Katherine Van Loon. 2018. “Emerging Treatment Options for Braf-Mutant Colorectal Cancer.” Gastrointestinal Cancer: Targets and Therapy 8. NIH Public Access: 13.

Van Calster, Ben, David J McLernon, Maarten Van Smeden, Laure Wynants, and Ewout W Steyerberg. 2019. “Calibration: The Achilles Heel of Predictive Analytics.” BMC Medicine 17 (1). BioMed Central: 1–7.

Van der Laan, Mark J, and Sherri Rose. 2011. Targeted Learning: Causal Inference for Observational and Experimental Data. Springer Science & Business Media.

Van der Laan, Mark J, Eric C Polley, and Alan E Hubbard. 2007. “Super Learner.” Statistical Applications in Genetics and Molecular Biology 6 (1). De Gruyter.

Van Kampen, NG. 2004. “Stochastic Processes in Physics and Chemistry. 5th.” Elsevier Amsterdam:

VanderWeele, Tyler J. 2009. “Concerning the Consistency Assumption in Causal Inference.” Epidemiology 20 (6). LWW: 880–83.

VanderWeele, Tyler J, and Miguel A Hernan. 2013. “Causal Inference Under Multiple Versions of Treatment.” Journal of Causal Inference 1 (1). De Gruyter: 1–20.

Van’t Veer, Laura J, Hongyue Dai, Marc J Van De Vijver, Yudong D He, Augustinus AM Hart, Mao Mao, Hans L Peterse, et al. 2002. “Gene Expression Profiling Predicts Clinical Outcome of Breast Cancer.” Nature 415 (6871). Nature Publishing Group: 530–36.

Venet, David, Jacques E Dumont, Vincent Detours, and others. 2011. “Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome.” PLoS Comput Biol 7 (10): e1002240.

Venter, J Craig, Mark D Adams, Eugene W Myers, Peter W Li, Richard J Mural, Granger G Sutton, Hamilton O Smith, et al. 2001. “The Sequence of the Human Genome.” Science 291 (5507). American Association for the Advancement of Science: 1304–51.

Verlingue, Loic, Laurence Calzone, Maud Kamal, Nicolas Servant, Lisa Belin, Emmanuel Barillot, and Christophe Le Tourneau. 2016. “In Silico Prediction of the Clinical Response to the MTOR Inhibitor Everolimus Using a Boolean Model: Validation from a Cohort of the Shiva Trial.” AACR.

Verlingue, Loic, Aurélien Dugourd, Gautier Stoll, Emmanuel Barillot, Laurence Calzone, and Arturo Londoño-Vallejo. 2016. “A Comprehensive Approach to the Molecular Determinants of Lifespan Using a Boolean Model of Geroconversion.” Aging Cell 15 (6). Wiley Online Library: 1018–26.

Verny, Louis, Nadir Sella, Séverine Affeldt, Param Priya Singh, and Hervé Isambert. 2017. “Learning Causal Networks with Latent Variables from Multivariate Information in Genomic Data.” PLOS Computational Biology 13 (10): e1005662. doi:10.1371/journal.pcbi.1005662.

Vert, Jean-Philippe, Jian Qiu, and William S. Noble. 2007. “A New Pairwise Kernel for Biological Network Inference with Support Vector Machines.” BMC Bioinformatics 8 (Suppl 10): S8.

Videla, Santiago, Julio Saez-Rodriguez, Carito Guziolowski, and Anne Siegel. 2017. “Caspo: A Toolbox for Automated Reasoning on the Response of Logical Signaling Networks Families.” Bioinformatics 33 (6): 947–50. doi:10.1093/bioinformatics/btw738.

Villaverde, Alejandro F, and Julio R Banga. 2014. “Reverse Engineering and Identification in Systems Biology: Strategies, Perspectives and Challenges.” Journal of the Royal Society Interface 11 (91). The Royal Society: 20130505.

Vis, Daniel J, Lorenzo Bombardelli, Howard Lightfoot, Francesco Iorio, Mathew J Garnett, and Lodewyk FA Wessels. 2016. “Multilevel Models Improve Precision and Speed of Ic50 Estimates.” Pharmacogenomics 17 (7). Future Medicine: 691–700.

Vollmer, Sebastian, Bilal A Mateen, Gergo Bohner, Franz J Király, Rayid Ghani, Pall Jonsson, Sarah Cumbers, et al. 2020. “Machine Learning and Artificial Intelligence Research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics, and Effectiveness.” Bmj 368. British Medical Journal Publishing Group.

Volterra, Vito. 1926. “Fluctuations in the Abundance of a Species Considered Mathematically.” Nature Publishing Group.

Von Hoff, Daniel D, Joseph J Stephenson Jr, Peter Rosen, David M Loesch, Mitesh J Borad, Stephen Anthony, Gayle Jameson, et al. 2010. “Pilot Study Using Molecular Profiling of Patients’ Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers.” Journal of Clinical Oncology 28 (33). American Society of Clinical Oncology: 4877–83.

Vucic, Emily A, Kelsie L Thu, Keith Robison, Leszek A Rybaczyk, Raj Chari, Carlos E Alvarez, and Wan L Lam. 2012. “Translating Cancer ‘Omics’ to Improved Outcomes.” Genome Research 22 (2). Cold Spring Harbor Lab: 188–95.

Wan, Frederick YM. 2018. Mathematical Models and Their Analysis. Vol. 79. SIAM.

Wang, Jing, Sijin Wen, W. Fraser Symmans, Lajos Pusztai, and Kevin R. Coombes. 2009. “The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data.” Cancer Informatics 7 (August): 199–216.

Wang, Yong, Jill Waters, Marco L Leung, Anna Unruh, Whijae Roh, Xiuqing Shi, Ken Chen, et al. 2014. “Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing.” Nature 512 (7513). Nature Publishing Group: 155–60.

Watson, James D, and Francis HC Crick. 1953. “Molecular Structure of Nucleic Acids.” Nature 171 (4356): 737–38.

Weinberg, Robert A. 2013. The Biology of Cancer. Garland science.

Weinstein, Nathan, Luis Mendoza, Isidoro Gitler, and Jaime Klapp. 2017. “A Network Model to Explore the Effect of the Micro-Environment on Endothelial Cell Behavior During Angiogenesis.” Frontiers in Physiology 8. Frontiers: 960.

Weisberg, Michael. 2007. “Three Kinds of Idealization.” The Journal of Philosophy 104 (12): 639–59.

Wellbrock, Claudia, Maria Karasarides, and Richard Marais. 2004. “The Raf Proteins Take Centre Stage.” Nature Reviews Molecular Cell Biology 5 (11). Nature Publishing Group: 875–85.

Wiens, Jenna, Suchi Saria, Mark Sendak, Marzyeh Ghassemi, Vincent X Liu, Finale Doshi-Velez, Kenneth Jung, et al. 2019. “Do No Harm: A Roadmap for Responsible Machine Learning for Health Care.” Nature Medicine 25 (9). Nature Publishing Group: 1337–40.

Wittig, Ulrike, Renate Kania, Martin Golebiewski, Maja Rey, Lei Shi, Lenneke Jong, Enkhjargal Algaa, et al. 2012. “SABIO-Rk—database for Biochemical Reaction Kinetics.” Nucleic Acids Research 40 (D1). Oxford University Press: D790–D796.

Woodhouse, Steven, Nir Piterman, Christoph M Wintersteiger, Berthold Göttgens, and Jasmin Fisher. 2018. “SCNS: A Graphical Tool for Reconstructing Executable Regulatory Networks from Single-Cell Genomic Data.” BMC Systems Biology 12 (1). BioMed Central: 59.

Wroblewski, David, Branka Mijatov, Nethia Mohana-Kumaran, Fritz Lai, Stuart J Gallagher, Nikolas K Haass, Xu Dong Zhang, and Peter Hersey. 2013. “The Bh3-Mimetic Abt-737 Sensitizes Human Melanoma Cells to Apoptosis Induced by Selective Braf Inhibitors but Does Not Reverse Acquired Resistance.” Carcinogenesis 34 (2). Oxford University Press UK: 237–47.

Yang, Wanjuan, Jorge Soares, Patricia Greninger, Elena J Edelman, Howard Lightfoot, Simon Forbes, Nidhi Bindal, et al. 2012. “Genomics of Drug Sensitivity in Cancer (Gdsc): A Resource for Therapeutic Biomarker Discovery in Cancer Cells.” Nucleic Acids Research 41 (D1). Oxford University Press: D955–D961.

Zañudo, Jorge Gómez Tejeda, Maurizio Scaltriti, and Réka Albert. 2017. “A Network Modeling Approach to Elucidate Drug Resistance Mechanisms and Predict Combinatorial Drug Treatments in Breast Cancer.” Cancer Convergence 1 (1). Springer: 5.